Literature DB >> 33550587

Heterogeneity of HSCs in a Mouse Model of NASH.

Sara Brin Rosenthal1,2, Xiao Liu2,3, Souradipta Ganguly2, Debanjan Dhar2, Martina P Pasillas4, Eugenia Ricciardelli5, Rick Z Li4, Ty D Troutman2, Tatiana Kisseleva3, Christopher K Glass2,4, David A Brenner2.   

Abstract

BACKGROUND AND AIMS: In clinical and experimental NASH, the origin of the scar-forming myofibroblast is the HSC. We used foz/foz mice on a Western diet to characterize in detail the phenotypic changes of HSCs in a NASH model. APPROACH AND
RESULTS: We examined the single-cell expression profiles (scRNA sequencing) of HSCs purified from the normal livers of foz/foz mice on a chow diet, in NASH with fibrosis of foz/foz mice on a Western diet, and in livers during regression of NASH after switching back to a chow diet. Selected genes were analyzed using immunohistochemistry, quantitative real-time PCR, and short hairpin RNA knockdown in primary mouse HSCs. Our analysis of the normal liver identified two distinct clusters of quiescent HSCs that correspond to their acinar position of either pericentral vein or periportal vein. The NASH livers had four distinct HSC clusters, including one representing the classic fibrogenic myofibroblast. The three other HSC clusters consisted of a proliferating cluster, an intermediate activated cluster, and an immune and inflammatory cluster. The livers with NASH regression had one cluster of inactivated HSCs, which was similar to, but distinct from, the quiescent HSCs.
CONCLUSIONS: Analysis of single-cell RNA sequencing in combination with an interrogation of previous studies revealed an unanticipated heterogeneity of HSC phenotypes under normal and injured states.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33550587      PMCID: PMC8346581          DOI: 10.1002/hep.31743

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  38 in total

1.  Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis.

Authors:  Derrick M Van Rooyen; Claire Z Larter; W Geoffrey Haigh; Matthew M Yeh; George Ioannou; Rahul Kuver; Sum P Lee; Narci C Teoh; Geoffrey C Farrell
Journal:  Gastroenterology       Date:  2011-06-23       Impact factor: 22.682

2.  Fat aussie--a new Alström syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis.

Authors:  Todor Arsov; Diego G Silva; Moira K O'Bryan; Amanda Sainsbury; Nicola J Lee; Claire Kennedy; Shehnaaz S M Manji; Keats Nelms; Conan Liu; Carola G Vinuesa; David M de Kretser; Christopher C Goodnow; Nikolai Petrovsky
Journal:  Mol Endocrinol       Date:  2006-03-02

3.  Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.

Authors:  Xiao Liu; Jun Xu; Sara Rosenthal; Ling-Juan Zhang; Ryan McCubbin; Nairika Meshgin; Linshan Shang; Yukinori Koyama; Hsiao-Yen Ma; Sonia Sharma; Sven Heinz; Chris K Glass; Chris Benner; David A Brenner; Tatiana Kisseleva
Journal:  Gastroenterology       Date:  2020-01-23       Impact factor: 33.883

4.  Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis.

Authors:  Oliver Krenkel; Jana Hundertmark; Thomas P Ritz; Ralf Weiskirchen; Frank Tacke
Journal:  Cells       Date:  2019-05-24       Impact factor: 6.600

5.  Resolving the fibrotic niche of human liver cirrhosis at single-cell level.

Authors:  P Ramachandran; R Dobie; J R Wilson-Kanamori; E F Dora; B E P Henderson; N T Luu; J R Portman; K P Matchett; M Brice; J A Marwick; R S Taylor; M Efremova; R Vento-Tormo; N O Carragher; T J Kendall; J A Fallowfield; E M Harrison; D J Mole; S J Wigmore; P N Newsome; C J Weston; J P Iredale; F Tacke; J W Pollard; C P Ponting; J C Marioni; S A Teichmann; N C Henderson
Journal:  Nature       Date:  2019-10-09       Impact factor: 49.962

Review 6.  Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis.

Authors:  Prakash Ramachandran; Kylie P Matchett; Ross Dobie; John R Wilson-Kanamori; Neil C Henderson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-01       Impact factor: 46.802

Review 7.  Pancreatic cancer stroma: an update on therapeutic targeting strategies.

Authors:  Abdel N Hosein; Rolf A Brekken; Anirban Maitra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-11       Impact factor: 73.082

8.  Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.

Authors:  Christine C Hsu; Juliane S Troeger; Ingmar Mederacke; Peter Huebener; Xueru Mu; Dianne H Dapito; Jean-Philippe Pradere; Robert F Schwabe
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  RNA velocity of single cells.

Authors:  Gioele La Manno; Ruslan Soldatov; Amit Zeisel; Emelie Braun; Hannah Hochgerner; Viktor Petukhov; Katja Lidschreiber; Maria E Kastriti; Peter Lönnerberg; Alessandro Furlan; Jean Fan; Lars E Borm; Zehua Liu; David van Bruggen; Jimin Guo; Xiaoling He; Roger Barker; Erik Sundström; Gonçalo Castelo-Branco; Patrick Cramer; Igor Adameyko; Sten Linnarsson; Peter V Kharchenko
Journal:  Nature       Date:  2018-08-08       Impact factor: 49.962

10.  SCENIC: single-cell regulatory network inference and clustering.

Authors:  Sara Aibar; Carmen Bravo González-Blas; Thomas Moerman; Vân Anh Huynh-Thu; Hana Imrichova; Gert Hulselmans; Florian Rambow; Jean-Christophe Marine; Pierre Geurts; Jan Aerts; Joost van den Oord; Zeynep Kalender Atak; Jasper Wouters; Stein Aerts
Journal:  Nat Methods       Date:  2017-10-09       Impact factor: 28.547

View more
  12 in total

1.  High throughput interrogation of human liver stellate cells reveals microenvironmental regulation of phenotype.

Authors:  Aidan Brougham-Cook; Ishita Jain; David A Kukla; Faisal Masood; Hannah Kimmel; Hyeon Ryoo; Salman R Khetani; Gregory H Underhill
Journal:  Acta Biomater       Date:  2021-11-17       Impact factor: 8.947

2.  Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment.

Authors:  Peng Zhang; Zhimin Chen; Henry Kuang; Tongyu Liu; Jiaqiang Zhu; Linkang Zhou; Qiuyu Wang; Xuelian Xiong; Ziyi Meng; Xiaoxue Qiu; Ramiah Jacks; Lu Liu; Siming Li; Carey N Lumeng; Qing Li; Xiang Zhou; Jiandie D Lin
Journal:  Cell Metab       Date:  2022-08-15       Impact factor: 31.373

3.  MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH.

Authors:  Hong Gao; Zhongmou Jin; Gautam Bandyopadhyay; Karina Cunha E Rocha; Xiao Liu; Huayi Zhao; Dinghong Zhang; Hani Jouihan; Soheil Pourshahian; Tatiana Kisseleva; David A Brenner; Wei Ying; Jerrold M Olefsky
Journal:  Cell Metab       Date:  2022-06-13       Impact factor: 31.373

Review 4.  Understanding the cellular interactome of non-alcoholic fatty liver disease.

Authors:  Sebastian J Wallace; Frank Tacke; Robert F Schwabe; Neil C Henderson
Journal:  JHEP Rep       Date:  2022-06-15

Review 5.  Hepatic Stellate Cell-Immune Interactions in NASH.

Authors:  James K Carter; Scott L Friedman
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 6.  Hepatic stellate cells in physiology and pathology.

Authors:  Dakota R Kamm; Kyle S McCommis
Journal:  J Physiol       Date:  2022-03-30       Impact factor: 6.228

7.  Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury.

Authors:  Wenjun Zhang; Simon J Conway; Ying Liu; Paige Snider; Hanying Chen; Hongyu Gao; Yunlong Liu; Kadir Isidan; Kevin J Lopez; Gonzalo Campana; Ping Li; Burcin Ekser; Heather Francis; Weinian Shou; Chandrashekhar Kubal
Journal:  Cells       Date:  2021-08-19       Impact factor: 6.600

8.  Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring.

Authors:  Michael J Nash; Evgenia Dobrinskikh; Sean A Newsom; Ilhem Messaoudi; Rachel C Janssen; Kjersti M Aagaard; Carrie E McCurdy; Maureen Gannon; Paul Kievit; Jacob E Friedman; Stephanie R Wesolowski
Journal:  JCI Insight       Date:  2021-12-22

Review 9.  Metabolic Reprogramming of Liver Fibrosis.

Authors:  M Eugenia Delgado; Beatriz I Cárdenas; Núria Farran; Mercedes Fernandez
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

10.  Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice.

Authors:  Wu Yang; Hao He; Tongtong Wang; Nan Su; Feng Zhang; Kai Jiang; Jing Zhu; Chonghe Zhang; Kongyan Niu; Luyue Wang; Xiaodong Yuan; Nan Liu; Lingjie Li; Wu Wei; Junhao Hu
Journal:  Hepatology       Date:  2021-08-21       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.